Thrombocytopenia impacts mortality and morbidity in ICU patients, indicating the need for effective strategies.
Thrombocytopenia is one of the most frequently encountered haematological abnormalities in critically ill patients, with reported incidence ranging from 13–65% [1]. It is defined as a platelet count <150,000/µL or a decline of >50% from baseline. The condition may develop due to multiple, often overlapping mechanisms, and its presence in ICU patients correlates with increased morbidity, mortality, and prolonged ICU stay.
No takes yet. Share an insight, caveat, or question.
Mohanty et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: